Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
418.34
617.85
475.99
438.94
326.91
1,037.10
138.01
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
418.34
617.85
475.99
438.94
326.91
1,037.10
138.01
Raw Material Cost
111.16
137.13
126.80
185.37
86.50
113.02
26.36
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
105.92
0.00
0.00
95.85
63.74
100.47
40.63
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.26
0.21
0.25
0.49
0.23
0.31
0.11
Selling and Distribution Expenses
88.54
148.92
95.55
84.68
73.66
148.86
64.89
Other Expenses
-2.19
9.19
4.89
-2.81
-3.60
-4.27
-2.04
Total Expenditure (Excl Depreciation)
283.97
378.15
271.54
338.32
188.18
320.00
111.57
Operating Profit (PBDIT) excl Other Income
134.4
239.7
204.4
100.60000000000001
138.7
717.0999999999999
26.400000000000002
Other Income
28.79
36.21
33.06
69.82
5.14
-29.02
1.90
Operating Profit (PBDIT)
193.79
300.37
243.54
189.54
156.25
681.29
29.10
Interest
0.26
0.21
0.25
0.49
0.23
0.31
0.11
Exceptional Items
5.83
7.06
-10.95
2.23
0.88
0.04
0.58
Gross Profit (PBDT)
307.18
480.72
349.19
253.58
240.41
924.08
111.65
Depreciation
36.02
29.69
32.92
25.72
19.10
6.57
2.85
Profit Before Tax
163.34
277.53
199.42
165.57
137.81
674.45
26.72
Tax
15.19
29.67
24.41
13.82
17.65
102.64
5.43
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
144.47
246.86
173.95
150.68
120.25
571.45
21.29
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
144.47
246.86
173.95
150.68
120.25
571.45
21.29
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
-0.09
0.36
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
144.47
246.86
173.95
150.68
120.16
571.81
21.29
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
0.0
0.0
0.0
Reserves
2,052.07
1,993.39
1,842.01
1,689.34
738.17
667.65
114.40
Earnings per share (EPS)
1.07
1.81
1.28
1.11
0.88
4.2
0.16
Diluted Earnings per share
1.07
1.81
1.28
1.11
0.88
4.2
0.16
Operating Profit Margin (Excl OI)
30.83%
37.95%
37.3%
21.42%
40.38%
67.86%
17.64%
Gross Profit Margin
47.65%
49.72%
48.81%
43.58%
48.0%
65.67%
21.43%
PAT Margin
34.53%
39.95%
36.54%
34.33%
36.78%
55.1%
15.43%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -32.30% vs 29.81% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -41.47% vs 41.98% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -37.55% vs 25.51% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 50.00% vs -33.33% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Innovita Biological Technology Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
418.34
0
418.34
Other Operating Income
0.00
0.00
0.00
Total Operating income
418.34
0
418.34
Raw Material Cost
111.16
0
111.16
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
105.92
0
105.92
Power Cost
0
0
0.00
Manufacturing Expenses
0.26
0
0.26
Selling and Distribution Expenses
88.54
0
88.54
Other Expenses
-2.19
0.00
-2.19
Total Expenditure (Excl Depreciation)
283.97
0
283.97
Operating Profit (PBDIT) excl Other Income
134.37
0.00
134.37
Other Income
28.79
0
28.79
Operating Profit (PBDIT)
193.79
0
193.79
Interest
0.26
0
0.26
Exceptional Items
5.83
0
5.83
Gross Profit (PBDT)
307.18
0
307.18
Depreciation
36.02
0
36.02
Profit Before Tax
163.34
0
163.34
Tax
15.19
0
15.19
Provisions and contingencies
0
0
0.00
Profit After Tax
144.47
0
144.47
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
144.47
0
144.47
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
144.47
0
144.47
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,052.07
0
2,052.07
Earnings per share (EPS)
1.07
0
1.07
Diluted Earnings per share
1.07
0
1.07
Operating Profit Margin (Excl OI)
30.83%
0%
0.00
30.83%
Gross Profit Margin
47.65%
0%
0.00
47.65%
PAT Margin
34.53%
0%
0.00
34.53%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 41.83 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -32.30% vs 29.81% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 14.45 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -41.47% vs 41.98% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.50 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -37.55% vs 25.51% in Dec 2024
Annual - Interest
Interest 0.03 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 50.00% vs -33.33% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.83%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






